Etid klinik pou BPCO nan New York
19 etid pou BPCO ap chèche patisipan nan sit nan New York.
Vil nan New York
Tèks ofisyèl etid la (Anglè)
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- New York Hospital Queens- Site Number : 8400058, Flushing
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07190209Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Mid Hudson Medical Research - New Windsor- Site Number : 8400004, New Windsor
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07190222A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Mount Kisco
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- Mount Sinai, Icahn School of Medicine, New York
- Columbia University, New York
- Cornell University, New York
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Buffalo
- Research Site, Cortland
- Research Site, Horseheads
- ak 2 plis
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Sep 3, 2026 · NCT06883305A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Staten Island
- Research Site, Syracuse
- Research Site, The Bronx
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Sep 3, 2026 · NCT06878261A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Northwell Health Physician Partners at Chappaqua, Chappaqua
- New York Presbyterian Queens, Flushing
- Northern Westchester Hospital, Mount Kisco
Ap rekriteFaz 2/3
Laj 35 a 80 · Tout sèks · Mizajou Aug 31, 2026 · NCT07363694A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Albany
- Research Site, Massapequa
- Research Site, New Windsor
- ak 3 plis
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Aug 26, 2026 · NCT06283966A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)
- Equity Medical LLC, New York
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 80 · Tout sèks · Mizajou Jul 1, 2026 · NCT06944925Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
- Icahn School of Medicine at Mount Sinai, New York
Ap rekrite
Laj 22 ak plis · Tout sèks · Mizajou Jun 23, 2026 · NCT07222410SPIROMICS Study of Early COPD Progression (SOURCE)
- Columbia University, New York
- Weill Cornell Medical Center, New York
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 30 a 55 · Tout sèks · Mizajou Jun 3, 2026 · NCT05033990Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Mount Kisco
- GSK Investigational Site, New Windsor
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Apr 9, 2026 · NCT06961214Evaluation Of The Lung Microbiome In NTM Bronchiectasis
- New York University School of Medicine, New York
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Feb 27, 2026 · NCT02779478Lung Microbiome and Inflammation in Early COPD
- New York University School of Medicine, New York
Ap rekriteEtid obsèvasyon
Laj 18 a 70 · Tout sèks · Mizajou Jan 28, 2026 · NCT02777879PiMZ Longitudinal Cohort (PiMZ Logic)
- Columbia University Irving Medical Center, New York
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jan 16, 2026 · NCT06505603Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
- Weill Cornell Medical College and Weill Cornell Medical Center, Department of Genetic Medicine, New York
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Nov 14, 2025 · NCT01776398Comprehensive Patient-Centered Home-based Care Coaching for COPD Self-management
- Ichan School of Medicine at Mount Sinai, New York
Ap rekrite
Laj 40 ak plis · Tout sèks · Mizajou Oct 6, 2025 · NCT06634810Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Our Lady of Lourdes Hospital, Binghamton
Ap rekriteEtid obsèvasyon
Laj 50 ak plis · Tout sèks · Mizajou Aug 5, 2025 · NCT06122077PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.
- Mount Sinai, New York
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Oct 12, 2023 · NCT05306743Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.